ロサルタンの世界市場レポート (2025年)

ロサルタンの市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.6％で17億9,000万米ドルに成長します。予測期間中の成長は、費用対効果の高い降圧剤に対する需要の増加、予防ヘルスケアへの注目の高まり、生活習慣病有病率の上昇、新興市場における医療アクセスの拡大、ジェネリック製剤の継続的な発売などの要因によるものと考えられます。この間の主な動向としては、ドラッグデリバリーの発展、合剤療法の開発、製剤技術の革新、製造プロセスの改善、個別化医療アプローチの開発などが挙げられます。

高血圧の有病率の増加は、近い将来のロサルタン市場の拡大を牽引すると予想されます。高血圧は持続的な高血圧を特徴とし、心臓病、脳卒中、その他の深刻な健康問題のリスクを高める。高血圧の増加は、しばしば塩分や加工食品の多い食生活に関連しており、これらは体液貯留を引き起こし、心臓への負担を増加させます。ロサルタンは、血管を収縮させるホルモンであるアンジオテンシンIIをブロックすることにより、高血圧の管理に役立ちます。この作用により、血管が弛緩して広がり、血圧が下がり、心臓の負担が軽減されます。例えば、米国心臓協会の報告によると、2024年1月、主に高血圧に関連した死亡者数は13万1,454人で、2021年の12万4,508人から増加しています。このような高血圧の有病率の上昇が、ロサルタンの需要を牽引しています。

ロサルタン市場の主要企業は、患者のコンプライアンスを改善し、治療用途を拡大する革新的な製品の創出に注力しています。そのような革新的な製品の一つがロサルタンカリウム経口懸濁液であり、錠剤を飲み込むのが困難な人のために設計されたロサルタンの液剤です。2025年3月、米国のバイオ医薬品会社サイエンチュア・ホールディングスは、高血圧治療、左室肥大を伴う高血圧患者の脳卒中リスク低減、2型糖尿病患者の糖尿病性腎症管理のための、すぐに使える液体製剤であるArbliのFDA承認を取得しました。Arbliは、配合剤を必要としない正確な投与が可能で、165mLのペパーミント風味の懸濁液（10mg/mL）で、室温で18ヶ月の保存が可能です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場のマクロ経済シナリオ：金利・インフレ・地政学・貿易戦争・関税・コロナ禍と回復が市場に及ぼす影響を含む

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のロサルタン市場：PESTEL分析（政治・社会・技術・環境・法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のロサルタン市場：成長率分析
• 世界のロサルタンの市場規模・成長率：実績値、2019～2024年
• 世界のロサルタンの市場規模・成長率：予測値、2024～2029年、2034年
• 世界のロサルタン市場：総有効市場（TAM）

第6章 市場セグメンテーション

• 世界のロサルタン市場：投与方式別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 錠剤
• 粉末
• 懸濁液（サスペンション）
• 世界のロサルタン市場：調達先別、実績値・予測値、2019～2024年、2024～2029年、2034年
• CMO（医薬品製造業務受託機関）
• 社内
• 世界のロサルタン市場：流通チャネル別、実績値・予測値、2019～2024年、2024～2029年、2034年
• オンライン
• オフライン
• 世界のロサルタン市場：用途別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 高血圧
• 脳卒中
• 糖尿病性腎症
• その他の用途
• 世界のロサルタン市場：エンドユーザー別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 成人
• 小児
• 世界のロサルタン市場：錠剤の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 25ミリグラム（mg）
• 50ミリグラム（mg）
• 100ミリグラム（mg）
• 世界のロサルタン市場：粉末の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 25ミリグラム（mg）
• 50ミリグラム（mg）
• 100ミリグラム（mg）
• 世界のロサルタン市場：懸濁液の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 5ミリグラム（mg）/5ミリリットル（mL）
• 10ミリグラム（mg）/5ミリリットル（mL）
• 25ミリグラム（mg）/5ミリリットル（mL）

第7章 地域別・国別の分析

• 世界のロサルタン市場：地域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 世界のロサルタン市場：国別、実績値・予測値、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ロサルタン市場：競合情勢
• ロサルタン市場：企業プロファイル
  • Viatris Inc.（概要、製品・サービス、戦略、財務分析）
  • Teva Pharmaceutical Industries Ltd（概要、製品・サービス、戦略、財務分析）
  • Intas Pharmaceuticals Ltd.（概要、製品・サービス、戦略、財務分析）
  • Sun Pharmaceutical Industries Ltd.（概要、製品・サービス、戦略、財務分析）
  • Apotex Inc.（概要、製品・サービス、戦略、財務分析）

第31章 その他の大手企業と革新的企業

• Aurobindo Pharma Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Cadila Pharmaceuticals Ltd.
• Lupin Ltd.
• Zydus Lifesciences Ltd.
• Torrent Pharmaceuticals Ltd.
• Alembic Pharmaceuticals Ltd.
• Vasudha Pharma Chem Ltd.
• Unichem Laboratories Ltd.
• Global Pharma Tek
• Manus Aktteva Biopharma LLP
• Emcure Pharmaceuticals Ltd.
• Wellona Pharma
• JPM Pharma & Chemicals Pvt. Ltd.

第32章 世界市場：競合ベンチマーキング・ダッシュボード

第33章 主要な企業合併・買収 (M&A)

第34章 最近の市場動向

第35章 市場の潜在力の高い国・部門と戦略

• ロサルタン市場：最新機会を提供する国（2029年）
• ロサルタン市場：最新機会を提供する部門（2029年）
• ロサルタン市場：成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競争戦略

第36章 付録

Losartan is an angiotensin II receptor blocker (ARB) commonly prescribed to treat high blood pressure and reduce the risk of stroke in patients with hypertension. It works by relaxing blood vessels, which makes it easier for the heart to pump blood. Losartan helps lower blood pressure, improves heart function, and protects kidney health, particularly in patients with diabetes.

The primary forms of losartan dosage include tablets, powder, and suspension. Losartan tablets are convenient, once-daily oral medications used to manage hypertension and diabetic nephropathy. It is sourced from various suppliers, including contract manufacturing organizations and in-house production, and is distributed through both online and offline channels. Losartan is used for a range of conditions, including hypertension, stroke, diabetic nephropathy, and more. It is suitable for use by a variety of end-users, including both adults and pediatrics.

The losartan market research report is one of a series of new reports from The Business Research Company that provides losartan market statistics, including the losartan industry global market size, regional shares, competitors with the losartan market share, detailed losartan market segments, market trends, and opportunities, and any further data you may need to thrive in the losartan industry. This losartan market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The losartan market size has grown steadily in recent years. It will grow from $1.44 billion in 2024 to $1.50 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth during the historic period can be attributed to factors such as the increasing geriatric population, rising healthcare expenditure, a rise in diabetic nephropathy cases, greater awareness of blood pressure management, and the growing adoption of generic ARBs.

The losartan market size is expected to see steady growth in the next few years. It will grow to $1.79 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth during the forecast period can be attributed to factors such as the increasing demand for cost-effective antihypertensive drugs, a growing focus on preventive healthcare, the rising prevalence of lifestyle-related disorders, expanded healthcare access in emerging markets, and the continuous launch of generic formulations. Key trends during this period include advancements in drug delivery systems, the development of fixed-dose combination therapies, innovation in formulation technologies, improved manufacturing processes, and the development of personalized medicine approaches.

The growing prevalence of hypertension is expected to drive the expansion of the losartan market in the near future. Hypertension, characterized by persistently high blood pressure, increases the risk of heart disease, stroke, and other serious health issues. The rise in hypertension is often linked to diets rich in salt and processed foods, which cause fluid retention and increase the strain on the heart. Losartan helps manage hypertension by blocking angiotensin II, a hormone that narrows blood vessels. This action relaxes and widens the vessels, lowering blood pressure and reducing the heart's burden. For example, the American Heart Association reported that in January 2024, there were 131,454 deaths primarily associated with high blood pressure in 2022, an increase from 124,508 deaths in 2021. This rising prevalence of hypertension is driving the demand for losartan.

Major companies in the losartan market are focusing on creating innovative products to improve patient compliance and expand therapeutic uses. One such innovation is the losartan potassium oral suspension, a liquid form of losartan designed for people who find it difficult to swallow tablets. In March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received FDA approval for Arbli, a ready-to-use liquid formulation for treating hypertension, reducing stroke risk in hypertensive patients with left ventricular hypertrophy, and managing diabetic nephropathy in type 2 diabetes patients. Arbli offers precise dosing without the need for compounding and comes in a 165 mL peppermint-flavored suspension (10 mg/mL), with an 18-month shelf life at room temperature.

In April 2025, Scienture Holdings, Inc. formed a partnership with Saptalis Pharmaceuticals to manufacture Arbli, a losartan potassium oral suspension (10 mg/mL). This collaboration includes warehousing and distribution agreements with strategic partners to ensure the successful market launch of the first FDA-approved ready-to-use oral liquid losartan, addressing the unmet needs in hypertension treatment. Saptalis Pharmaceuticals, based in the United States, is a key partner in this initiative.

Major players in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

North America was the largest region in the losartan market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in losartan report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the losartan market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The losartan market consists of sales of losartan potassium tablets, losartan-hydrochlorothiazide combination tablets, and generic formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Losartan Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on losartan market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for losartan ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The losartan market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Dosage: Tablet; Powder; Suspension
• 2) By Source: Contract Manufacturing Organizations; In-House
• 3) By Distribution Channel: Online; Offline
• 4) By Application: Hypertension; Stroke; Diabetic Nephropathy; Other Applications
• 5) By End-User: Adult; Pediatric
• Subsegments:
• 1) By Tablet: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)
• 2) By Powder: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)
• 3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL); 10 Milligrams (mg) Per 5 Milliliters (mL); 25 Milligrams (mg) Per 5 Milliliters (mL)
• Companies Mentioned: Viatris Inc.; Teva Pharmaceutical Industries Ltd; Intas Pharmaceuticals Ltd.; Sun Pharmaceutical Industries Ltd.; Apotex Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Losartan Market Characteristics

3. Losartan Market Trends And Strategies

4. Losartan Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Losartan Growth Analysis And Strategic Analysis Framework

• 5.1. Global Losartan PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Losartan Market Growth Rate Analysis
• 5.4. Global Losartan Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Losartan Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Losartan Total Addressable Market (TAM)

6. Losartan Market Segmentation

• 6.1. Global Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet
• Powder
• Suspension
• 6.2. Global Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Manufacturing Organizations
• In-House
• 6.3. Global Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.4. Global Losartan Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypertension
• Stroke
• Diabetic Nephropathy
• Other Applications
• 6.5. Global Losartan Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult
• Pediatric
• 6.6. Global Losartan Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25 Milligrams (mg)
• 50 Milligrams (mg)
• 100 Milligrams (mg)
• 6.7. Global Losartan Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25 Milligrams (mg)
• 50 Milligrams (mg)
• 100 Milligrams (mg)
• 6.8. Global Losartan Market, Sub-Segmentation Of Suspension, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 5 Milligrams (mg) Per 5 Milliliters (mL)
• 10 Milligrams (mg) Per 5 Milliliters (mL)
• 25 Milligrams (mg) Per 5 Milliliters (mL)

7. Losartan Market Regional And Country Analysis

• 7.1. Global Losartan Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Losartan Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Losartan Market

• 8.1. Asia-Pacific Losartan Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Losartan Market

• 9.1. China Losartan Market Overview
• 9.2. China Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Losartan Market

• 10.1. India Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Losartan Market

• 11.1. Japan Losartan Market Overview
• 11.2. Japan Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Losartan Market

• 12.1. Australia Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Losartan Market

• 13.1. Indonesia Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Losartan Market

• 14.1. South Korea Losartan Market Overview
• 14.2. South Korea Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Losartan Market

• 15.1. Western Europe Losartan Market Overview
• 15.2. Western Europe Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Losartan Market

• 16.1. UK Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Losartan Market

• 17.1. Germany Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Losartan Market

• 18.1. France Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Losartan Market

• 19.1. Italy Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Losartan Market

• 20.1. Spain Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Losartan Market

• 21.1. Eastern Europe Losartan Market Overview
• 21.2. Eastern Europe Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Losartan Market

• 22.1. Russia Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Losartan Market

• 23.1. North America Losartan Market Overview
• 23.2. North America Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Losartan Market

• 24.1. USA Losartan Market Overview
• 24.2. USA Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Losartan Market

• 25.1. Canada Losartan Market Overview
• 25.2. Canada Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Losartan Market

• 26.1. South America Losartan Market Overview
• 26.2. South America Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Losartan Market

• 27.1. Brazil Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Losartan Market

• 28.1. Middle East Losartan Market Overview
• 28.2. Middle East Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Losartan Market

• 29.1. Africa Losartan Market Overview
• 29.2. Africa Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Losartan Market Competitive Landscape And Company Profiles

• 30.1. Losartan Market Competitive Landscape
• 30.2. Losartan Market Company Profiles
  • 30.2.1. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Losartan Market Other Major And Innovative Companies

• 31.1. Aurobindo Pharma Ltd.
• 31.2. Dr. Reddy's Laboratories Ltd.
• 31.3. Cipla Ltd.
• 31.4. Cadila Pharmaceuticals Ltd.
• 31.5. Lupin Ltd.
• 31.6. Zydus Lifesciences Ltd.
• 31.7. Torrent Pharmaceuticals Ltd.
• 31.8. Alembic Pharmaceuticals Ltd.
• 31.9. Vasudha Pharma Chem Ltd.
• 31.10. Unichem Laboratories Ltd.
• 31.11. Global Pharma Tek
• 31.12. Manus Aktteva Biopharma LLP
• 31.13. Emcure Pharmaceuticals Ltd.
• 31.14. Wellona Pharma
• 31.15. JPM Pharma & Chemicals Pvt. Ltd.

32. Global Losartan Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Losartan Market

34. Recent Developments In The Losartan Market

35. Losartan Market High Potential Countries, Segments and Strategies

• 35.1 Losartan Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Losartan Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Losartan Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer